Skip to main content
. 2023 Jul 12;14:1213285. doi: 10.3389/fimmu.2023.1213285

Figure 4.

Figure 4

(A) Schema of study design, with data presented in (B, C). (B) Tumor growth curve of C3.43 tumor bearing mice vaccinated with either a single dose or 2 doses (10 days apart) of HPV vaccine mRNA or Luciferase control mRNA. N=5 mice per group. Data presented as mean ± SEM. (C) Survival rates of C3.43 tumor bearing mice vaccinated with either a single dose or 2 doses (10 days apart) of HPV vaccine mRNA or Luciferase control mRNA. N=5 mice per group. Data presented as Kaplan-Meier curves.